Xenoport to be acquired By: MarketMinute.com Stock News May 23, 2016 at 14:21 PM EDT Arbor Pharmaceuticals will acquire Xenoport Inc. (Nasdaq: XNPT) for a premium of approximately $467 million in cash. The stock price leaped $2.49 to $6.89.